ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,935Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 663

$588K Total Retail Price of All Prescriptions

Rank: 42 out of 663

879 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
8% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 879 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

14% of this provider’s 879 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 13,529 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
SIMVASTATIN 1,135 1,054 1 1
OMEPRAZOLE 807 696 2 4
ATENOLOL 635 601 3 10
AMLODIPINE BESYLATE 555 516 4 5
LISINOPRIL 509 464 5 2
METOPROLOL TARTRATE 424 391 6 11
HYDROCODONE-ACETAMINOPHEN 394 358 S3 7 6
TERAZOSIN HCL 365 333 8 38
METFORMIN HCL 336 310 9 9
LEVOTHROID 326 307 10 19
FUROSEMIDE 292 276 11 7
OXYCODONE-ACETAMINOPHEN 275 229 S2 12 26
GLIPIZIDE 264 254 13 29
LEVOTHYROXINE SODIUM 256 234 14 3
WARFARIN SODIUM 254 249 15 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 248 221 16 22
HYDROCHLOROTHIAZIDE 248 248 16 12
LOSARTAN POTASSIUM 233 224 18 14
ALENDRONATE SODIUM 223 213 19 15
PRAVASTATIN SODIUM 220 215 20 21
GABAPENTIN 219 190 21 20
ATORVASTATIN CALCIUM 190 170 22 13
INSULIN SYRINGE 187 157 23 55
NOVOLIN N 185 155 24 44
FLUTICASONE PROPIONATE 174 157 25 27
ALLOPURINOL 173 173 26 28
TAMSULOSIN HCL 173 153 26 24
PREDNISONE 163 153 28 39
FLUOXETINE HCL 162 127 29 32
K-TAB 158 155 30 36
OXYCODONE HCL 143 110 S2 31 41
RANITIDINE HCL 138 120 32 31
LOVASTATIN 137 132 33 30
PROAIR HFA 134 122 34 33
DIGOXIN 134 134 34 50
TRAZODONE HCL 127 110 36 34
TRAMADOL HCL 121 119 37 17
ZOLPIDEM TARTRATE 110 97 38 16
CLOPIDOGREL 110 101 38 65
CITALOPRAM HBR 108 96 40 18
NOVOLIN R 99 79 41 106
DONEPEZIL HCL 94 94 42 40
OXYBUTYNIN CHLORIDE 93 72 43 99
ISOSORBIDE MONONITRATE ER 91 77 44 93
ESTRADIOL 88 67 R 45 66
NORTRIPTYLINE HCL 87 76 46 63
VERAPAMIL ER 84 80 47 129
FINASTERIDE 83 76 48 56
DOXYCYCLINE HYCLATE 80 74 49 118
TRIAMTERENE-HCTZ 76 76 50 42
MORPHINE SULFATE ER 70 58 S2 51 51
DILT-XR 66 66 52 100
TRIAMTERENE-HYDROCHLOROTHIAZID 66 63 52 49
TRIAMCINOLONE ACETONIDE 64 61 54 137
FENOFIBRATE 64 59 54 97
PLAVIX 57 53 56 104
QVAR 56 51 57 91
SERTRALINE HCL 55 47 58 35
CARBIDOPA-LEVODOPA 55 51 58 102
CIPROFLOXACIN HCL 54 52 60 74
METOPROLOL SUCCINATE 51 49 61 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 5, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.